Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca — Sponsor Intelligence | 19 EU Trials

Filter these 19 trials by condition, phase, country and more.

Open in Search →

19 Registered trials

9 Recruiting

2 Completed trials

2 Countries active

39 Unique IMPs

100% Results reported

Phase II

Phase IV

Phase I

Phase III: 1 Phase II: 3 Phase I/II: 1 Phase III/IV: 1 Phase IV: 11 Phase I: 2

Oversight events:

1 serious breach 4 temporary halts across 3 trials

View oversight register →

100%

2 of 2 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Migraine 1 Strongyloidiasis 1

Top IMPs

DAPAGLIFLOZIN PROPANEDIOL 2 ISONIAZID, PYRAZINAMIDE, RIFAMPICIN, ETHAMBUTOL HYDROCHLORIDE 2 RIFAMPICIN 2 SEMAGLUTIDE 2 BASILIXIMAB 1 GADOBUTROL 1 GADOPICLENOL 1 LINEZOLID 1 MARIBAVIR 1 METHYLPREDNISOLONE 1 MOXIFLOXACIN HYDROCHLORIDE 1 MYCOPHENOLATE MOFETIL 1

All trials

19 total

Phase I, single and multiple ascending dose, randomized, double-blind, placebo-controlled, parallel-group clinical trial to evaluate the saf… Not authorised

2024-518758-18-00 Phase I 1 country
Insulin resistance in type 2 diabetes: evaluating the pathogenic mechanisms of insulin resistance in the myocardium and the effects of the t… Not authorised

2025-523374-17-01 Phase IV 1 country DAPAGLIFLOZIN PROPANEDIOL; SEMAGLUTIDE
Tolerability and acceptance of two oral hydrocortisone medications for Pediatrics. Pending

2024-519149-31-00 Phase IV 1 country
MULTICENTER, RANDOMIZED STUDY TO EVALUATE THE EFFICACY OF INDIVIDUALIZATION OF IMMUNOLOGICAL RISK BASED ON SELECTIVE BIOMARKERS (HLA EPLE… Pending

2025-520884-42-00 Phase IV 1 country BASILIXIMAB; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; PREDNISONE; RABBIT ANTI-…
Phase IV, single-center, randomized, crossover clinical trial to validate the use of gadopiclenol versus gadobutrol in the evaluation of mag… Pending

2025-523278-18-00 Phase IV 1 country GADOBUTROL; GADOPICLENOL
Insulin resistance in type 2 diabetes: evaluating the pathogenic mechanisms of insulin resistance in the myocardium and the effects of the t… Pending

2025-523374-17-03 Phase IV 1 country DAPAGLIFLOZIN PROPANEDIOL; SEMAGLUTIDE
Optimizing Aspirin Use for Preeclampsia Prevention Pending

2025-524646-94-00 Phase III/IV 1 country
Phase IV study to evaluate the safety and efficacy of maribavir in reducing Epstein–Barr virus in young adult kidney transplant recipients. Pending

2025-524786-25-00 Phase IV 1 country MARIBAVIR
Phase IV, randomized, open label, parallel groups clinical trial for evaluating the early Stop of antibiotic Treatment in high-risk febrile … Recruiting

2025-524264-38-00 Phase IV 1 country
Randomized Cross-Over Experimental Trial of Treatment with Sumatriptan vs. Rimegepant During Nitroglycerin (NTG)-Induced Headache in Patient… Recruiting

2024-519770-38-00 Phase IV 1 country
Phase I, single and multiple ascending dose, randomized, double-blind, placebo-controlled, parallel-group clinical trial to evaluate the saf… Recruiting

2024-518758-18-02 Phase I 1 country
A randomized controlled study to assess the efficacy of topical Sinecathechins used as adjuvant therapy to topical ablative trichloroacetic … Recruiting

2024-519782-21-00 Phase IV 1 country
Clinical trial with ivermectin to treat strongyloidiasis with the aim of demonstrating that both the independent and weight-dependent dose o… Recruiting

2024-515968-32-00 Phase II 1 country
Rifampicin at High Dose for Difficult-to-Treat Tuberculosis (RIAlta) study Recruiting

2024-519983-42-00 Phase II 2 countries ISONIAZID, PYRAZINAMIDE, RIFAMPICIN, ETHAMBUTOL HYDROCHLORIDE; RIFAMPICIN
Clinical Efficacy of oral Fosfomycin Trometamol and Cefixime in the Treatment of Acute Bacterial Prostatitis (CEFOSPROST): a comparative, ra… Recruiting

2024-513465-39-00 Phase IV 1 country
Preoperative Indocyanine Green administration increases intraoperative detection of Liver Tumors in Imaging-guided surgery. A phase IV clini… Recruiting

2023-508316-27-00 Phase IV 1 country
Multicenter, randomized, double-blind, comparative clinical trial to assess the efficacy of Zinc Acexamate versus a placebo in improving the… Recruiting

2024-518242-24-00 Phase III 1 country ZINC ACEXAMATE
IMMUNE RESET TO ALLOW ACCESS TO HLA-COMPATIBLE KIDNEY TRANSPLANTATION IN HYPERIMMUNIZED PATIENTS Ended

2023-506478-11-01 Phase I/II 1 country
RANDOMIZED, CONTROLLED, OPEN, MULTICENTRIC CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A COMBINATION OF ANTI-TUBERCULOUS DRUGS BAS… Ended

2023-509075-17-00 Phase II 1 country ISONIAZID, PYRAZINAMIDE, RIFAMPICIN, ETHAMBUTOL HYDROCHLORIDE; LINEZOLID; MOXIFL…

Showing 1–19 of 19 trials

← All sponsors A–Z